Shufro Rose & CO LLC Abbott Laboratories Transaction History

Shufro Rose & CO LLC

  • $1.22 Billion
  • Q2 2024

A detailed history of Shufro Rose & CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Shufro Rose & CO LLC holds 3,239 shares of ABT stock, worth $364,840. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,239
Previous 3,319 2.41%
Holding current value
$364,840
Previous $377,000 10.88%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$100.73 - $112.44 $8,058 - $8,995
-80 Reduced 2.41%
3,239 $336,000
Q1 2024

May 08, 2024
SELL
$109.52 - $120.96 $16,428 - $18,144
-150 Reduced 4.32%
3,319 $377,000
Q4 2023

Feb 05, 2024
BUY
$90.19 - $110.4 $54,114 - $66,240
600 Added 20.91%
3,469 $381,000
Q3 2023

Oct 25, 2023
SELL
$95.53 - $114.62 $4,776 - $5,731
-50 Reduced 1.71%
2,869 $277,000
Q1 2023

Apr 19, 2023
SELL
$96.86 - $114.01 $9,686 - $11,401
-100 Reduced 3.31%
2,919 $295,000
Q4 2022

Jan 25, 2023
SELL
$95.06 - $111.52 $15,494 - $18,177
-163 Reduced 5.12%
3,019 $0
Q3 2022

Oct 24, 2022
SELL
$96.76 - $112.03 $3,676 - $4,257
-38 Reduced 1.18%
3,182 $308,000
Q2 2022

Jul 22, 2022
SELL
$102.07 - $123.37 $116,257 - $140,518
-1,139 Reduced 26.13%
3,220 $350,000
Q1 2022

May 09, 2022
BUY
$114.02 - $139.04 $15,506 - $18,909
136 Added 3.22%
4,359 $516,000
Q4 2021

Jan 27, 2022
SELL
$115.53 - $141.46 $11,553 - $14,146
-100 Reduced 2.31%
4,223 $594,000
Q3 2021

Nov 05, 2021
BUY
$116.66 - $129.06 $180,939 - $200,172
1,551 Added 55.95%
4,323 $511,000
Q1 2021

Apr 28, 2021
SELL
$108.84 - $128.23 $21,768 - $25,645
-200 Reduced 6.73%
2,772 $332,000
Q4 2020

Feb 03, 2021
SELL
$105.0 - $114.42 $38,115 - $41,534
-363 Reduced 10.88%
2,972 $325,000
Q3 2020

Oct 27, 2020
SELL
$91.64 - $111.29 $2,291 - $2,782
-25 Reduced 0.74%
3,335 $363,000
Q1 2020

Apr 22, 2020
SELL
$62.82 - $91.86 $21,987 - $32,151
-350 Reduced 9.43%
3,360 $265,000
Q4 2018

Feb 01, 2019
BUY
$65.56 - $74.27 $6,556 - $7,427
100 Added 2.77%
3,710 $268,000
Q3 2018

Oct 26, 2018
BUY
$60.81 - $73.36 $219,524 - $264,829
3,610 New
3,610 $265,000
Q2 2018

Jul 27, 2018
SELL
$57.57 - $63.54 $192,859 - $212,859
-3,350 Closed
0 $0
Q1 2018

May 04, 2018
SELL
$56.27 - $63.62 $8,440 - $9,543
-150 Reduced 4.29%
3,350 $201,000
Q4 2017

Feb 06, 2018
SELL
$53.68 - $57.47 $182,512 - $195,398
-3,400 Reduced 49.28%
3,500 $200,000
Q3 2017

Nov 13, 2017
BUY
$48.06 - $53.64 $331,614 - $370,116
6,900
6,900 $368,000

Others Institutions Holding ABT

# of Institutions
3,137
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Shufro Rose & CO LLC Portfolio

Follow Shufro Rose & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shufro Rose & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email